Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T cell costimulatory pathway encompasses a network of receptor-ligand interactions crucial for orchestrating adaptive immunity. It provides secondary signals, alongside TCR engagement, that are essential for full activation, proliferation, and differentiation of T cells. Key components include receptors on T cells (CD28, ICOS, 4-1BB, OX40) and their ligands on antigen-presenting cells (B7-1/CD80, B7-2/CD86). This pathway regulates the balance between effective immunity and tolerance, influencing effector function development, memory generation, regulatory/suppressive functions, and maintenance of self-tolerance. Manipulation of these pathways has therapeutic potential in autoimmunity, transplantation rejection prevention, cancer immunotherapy, and infectious diseases.
Modulation of T cell activation signals through receptor-ligand interactions, influencing downstream signaling pathways like PI3K/Akt, NFκB, and MAPK/ERK to promote or inhibit T cell responses.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Cell Costimulatory Pathway.